Volume 1, 2022

Open a new window in the world of circulating microRNAs by merging ChemiRNA Tech with a Luminex platform

Abstract

microRNAs are small noncoding RNA molecules showing huge promise as biomarkers and diagnostic tools for illnesses, as significant changes in their expression occur in response to pathological states. However, multiplex detection of microRNAs represents a major challenge towards the use of microRNA signatures. Hence, our group has tackled this need by developing an accurate and PCR-free approach to detect multiple microRNAs in serum samples. ChemiRNA Tech has been refined to be merged with a Luminex xMAP system. The combination of these two technologies has created a unique bead-based multiplex assay capable of simultaneously measuring miR-122-5p, miR-451a-5p and miR-193a-5p in only 10 μL of serum. This novel multiplex assay for the direct quantitative measurement of circulating microRNA signatures offers benefits over gold standard singleplex assay techniques in terms of cost, time savings and ease of use.

Graphical abstract: Open a new window in the world of circulating microRNAs by merging ChemiRNA Tech with a Luminex platform

Supplementary files

Article information

Article type
Paper
Submitted
29 Jun 2022
Accepted
19 Sep 2022
First published
05 Oct 2022
This article is Open Access
Creative Commons BY license

Sens. Diagn., 2022,1, 1243-1251

Open a new window in the world of circulating microRNAs by merging ChemiRNA Tech with a Luminex platform

A. Marín-Romero, M. Tabraue-Chávez, J. W. Dear, J. J. Díaz-Mochón and S. Pernagallo, Sens. Diagn., 2022, 1, 1243 DOI: 10.1039/D2SD00111J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements